Insulin receptor substrate 1
The IRS1 gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene cause insulin resistance and type 2 diabetes.
Genetests:
Related Diseases:
References:
1. |
Myers MG et al. (1994) The IRS-1 signaling system.
|
2. |
Wu A et al. (2008) Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes.
|
3. |
Shi B et al. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells.
|
4. |
Zhang J et al. (2008) The cell growth suppressor, mir-126, targets IRS-1.
|
5. |
Rung J et al. (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.
|
6. |
Houghton AM et al. (2010) Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.
|
7. |
Song R et al. (2013) Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.
|
8. |
Clausen JO et al. (1995) Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.
|
9. |
Nishiyama M et al. (1994) The human insulin receptor substrate-1 gene (IRS1) is localized on 2q36.
|
10. |
Böhni R et al. (1999) Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4.
|
11. |
Laakso M et al. (1994) Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.
|
12. |
Almind K et al. (1993) Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.
|
13. |
Stoffel M et al. (1993) Human insulin receptor substrate-1 gene (IRS1): chromosomal localization to 2q35-q36.1 and identification of a simple tandem repeat DNA polymorphism.
|
14. |
Araki E et al. (1993) Human skeletal muscle insulin receptor substrate-1. Characterization of the cDNA, gene, and chromosomal localization.
|
15. |
Almind K et al. (1996) A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
|
16. |
Esposito DL et al. (1996) Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus.
|
17. |
Ogihara T et al. (1997) 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain.
|
18. |
Abe H et al. (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.
|
19. |
Taniguchi CM et al. (2005) Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.
|
20. |
Hart LM et al. (1999) Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study.
|
21. |
Porzio O et al. (1999) The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.
|
22. |
Baroni MG et al. (1999) A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease.
|
23. |
Kulkarni RN et al. (1999) Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.
|
24. |
Kido Y et al. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
|
25. |
Ogata N et al. (2000) Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.
|
26. |
Hribal ML et al. (2000) The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.
|
27. |
Clancy DJ et al. (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein.
|
28. |
Esposito DL et al. (2003) A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.
|
29. |
Marini MA et al. (2003) The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients.
|
30. |
Nishiyama M et al. (1992) Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma.
|
31. |
Abate N et al. (2003) Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance.
|
32. |
Federici M et al. (2004) G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.
|
33. |
Drakas R et al. (2004) Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase.
|
34. |
Perticone F et al. (2004) Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene.
|
35. |
Kim JK et al. (2004) PKC-theta knockout mice are protected from fat-induced insulin resistance.
|
36. |
Sun XJ et al. (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.
|
37. |
NCBI article
NCBI 3667
|
38. |
OMIM.ORG article
Omim 147545
|
39. |
Wikipedia article
Wikipedia EN (IRS1)
|
Update: Aug. 14, 2020